Alessandro Salvalaggio Selected Research

Alessandro Salvalaggio Research Topics

Disease

6	Polyneuropathies (Polyneuropathy) 04/2024 - 01/2019
6	Amyloidosis 04/2024 - 01/2022
5	Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) 01/2024 - 01/2019
4	Transthyretin-Related Hereditary Amyloidosis 04/2024 - 01/2021
4	Neoplasms (Cancer) 12/2022 - 06/2016
3	Waldenstrom Macroglobulinemia (Macroglobulinemia) 01/2023 - 01/2020
2	Neurolymphomatosis 01/2023 - 01/2019
2	Peripheral Nervous System Diseases (PNS Diseases) 01/2023 - 03/2022
2	Paraproteinemias (Monoclonal Gammopathy) 01/2023 - 03/2022
2	Tremor (Tremors) 01/2020 - 01/2019
1	POEMS Syndrome (Syndrome, POEMS) 04/2024
1	Rare Diseases (Rare Disease) 04/2024
1	Chest Pain (Chest Pains) 10/2023
1	Coronary Artery Disease (Coronary Atherosclerosis) 10/2023
1	Acute Coronary Syndrome 10/2023
1	Heart Failure 10/2023
1	Vasculitis (Vasculitides) 01/2023
1	Orthostatic Hypotension (Postural Hypotension) 01/2023
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2023
1	Ependymoma 01/2023
1	Immunoglobulin Light-chain Amyloidosis 01/2023
1	Hairy Cell Leukemia 01/2023
1	Lymphoma (Lymphomas) 01/2023
1	Monoclonal Gammopathy of Undetermined Significance 01/2023
1	Pain (Aches) 01/2023
1	Chemotherapy-Related Cognitive Impairment 12/2022
1	Disease Progression 04/2022
1	Hematologic Neoplasms (Hematological Malignancy) 03/2022
1	Diabetic Neuropathies (Diabetic Neuropathy) 01/2022
1	Glomerulonephritis 01/2022
1	Hypotension (Low Blood Pressure) 01/2022
1	Pyelonephritis 01/2022
1	Familial Amyloid Neuropathies (Familial Amyloid Polyneuropathy) 01/2022
1	Renal Insufficiency (Renal Failure) 01/2022
1	Proteostasis Deficiencies 12/2021
1	Paraneoplastic Polyneuropathy 01/2021
1	Guillain-Barre Syndrome 01/2021
1	Turcot syndrome 09/2020
1	Glioma (Gliomas) 09/2020
1	Ataxia (Dyssynergia) 01/2020
1	Malnutrition (Nutritional Deficiencies) 01/2019
1	Infections 01/2019
1	Multiple Myeloma 09/2016
1	Atrophy 06/2016

Drug/Important Bio-Agent (IBA)

5	Proteins (Proteins, Gene)FDA Link 01/2024 - 01/2020
4	Prealbumin (Transthyretin)IBA 04/2024 - 01/2022
4	Amyloid (Amyloid Fibrils)IBA 04/2024 - 01/2022
3	Immunoglobulin M (IgM)IBA 04/2024 - 01/2023
3	Biomarkers (Surrogate Marker)IBA 10/2023 - 01/2021
3	Myelin-Associated GlycoproteinIBA 01/2023 - 01/2020
3	AntibodiesIBA 01/2023 - 01/2019
3	Intravenous Immunoglobulins (IVIG)FDA Link 01/2023 - 01/2019
2	ParaproteinsIBA 04/2024 - 03/2022
2	Brain Natriuretic Peptide (Natrecor)FDA Link 10/2023 - 01/2022
2	Temozolomide (Temodar)FDA LinkGeneric 01/2023 - 09/2020
2	Immunoglobulin G (IgG)IBA 01/2020 - 01/2019
1	patisiranIBA 04/2024
1	SteroidsIBA 01/2024
1	Troponin IIBA 10/2023
1	hydroxide ionIBA 01/2023
1	CryoglobulinsIBA 01/2023
1	Lapatinib (GW572016)FDA Link 01/2023
1	TroponinIBA 01/2022
1	InotersenIBA 01/2022
1	DNA-Binding Proteins (DNA Binding Protein)IBA 12/2021
1	AlbuminsIBA 01/2021
1	Oligoclonal BandsIBA 01/2021
1	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 10/2020
1	Agammaglobulinaemia Tyrosine KinaseIBA 01/2020
1	ibrutinibIBA 01/2020
1	Rituximab (Mabthera)FDA Link 01/2019
1	Glycoproteins (Glycoprotein)IBA 01/2019
1	Methylprednisolone FDA LinkGeneric 01/2019
1	Immunoglobulins (Immunoglobulin)IBA 01/2019
1	Lenalidomide (CC 5013)FDA Link 09/2016
1	Hormones (Hormone)IBA 06/2016

Therapy/Procedure

6	Therapeutics 01/2024 - 09/2016
2	Drug Therapy (Chemotherapy) 12/2022 - 01/2019
1	Radiotherapy 01/2023
1	Aftercare (After-Treatment) 01/2020